계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
H&Q Healthcare Investors
investment firm
About
H&Q Healthcare Investors provides early and later stage funding and is a Massachusetts-based healthcare fund.
Highlights
Details
- Operating Status
- Active
- Investor Type
- Venture Capital
Investments
Number of Investments
Number of Lead Investments
10
1
H&Q Healthcare Investors has made 10 investments. Their most recent investment was on
Apr 3, 2014, when Neurovance raised $6.30M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Apr 3, 2014
Neurovance
|
Series A | $6.30M | Biotechnology | — |
|
Mar 1, 2013
CardioKinetix
|
Series E | $23M | Biotechnology | — |
|
Jan 8, 2013
Labcyte
|
Series D | $5.30M | Alternative Medicine | — |
|
Oct 18, 2012
Neurovance
|
Series Unknown | $7M | Biotechnology | — |
|
Oct 5, 2011
Puma Biotechnology
|
Post-IPO Equity | $55M | Biotechnology | — |
Exits
H&Q Healthcare Investors has had 6 exits. H&Q Healthcare Investors most notable exits include Labcyte , Neurovance
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Jan 30, 2019 | Labcyte | M&A | Alternative Medicine | Detail |
| Mar 2, 2017 | Neurovance | M&A | Biotechnology | Detail |
| May 11, 2015 | PHT Corporation | M&A | Clinical Trials | Detail |
| Apr 20, 2012 | Puma Biotechnology | IPO | Biotechnology | Detail |
| Mar 19, 2008 | CardioNet | IPO | Biotechnology | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
